SPK 843 Kaken phase change II, Japan (mycosis).

Kaken reported on 28 November 2005 that a phase II trial of SPK 843 is under way in Japan for the treatment of systemic mycosis. The agent, a polyene antibiotic, is being developed in collaboration with SPA.

Antifungal name: 

Date of article/Start date of trial: 

Monday, January 9, 2006

Trial phase: 

Phase 2

Trial status: 

Active
New antifungal drugs